Donna M. Graham

Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study

Dominic G. Rothwell, Mahmood Ayub, Natalie Cook et al. · Nature Medicine · 2019 · 306 citations · Full text

Medicine, Oncology, Radiology +10

Cumulative Antibiotic Use Significantly Decreases Efficacy of Checkpoint Inhibitors in Patients with Advanced Cancer

Nadina Tinsley, Cong Zhou, Grace Tan et al. · The Oncologist · 2019 · 202 citations · Full text

Medicine, Immunology, Oncology +16

Benthic and Pelagic Secondary Production in Lake Erie after the Invasion of Dreissena spp. with Implications for Fish Production

Ora E. Johannsson, Ron Dermott, Donna M. Graham et al. · Journal of Great Lakes Research · 2000 · 162 citations

Life Sciences, Ecology, Oceanography +16

LBA41 LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours

Zarnie Lwin, Carlos Gomez‐Roca, Esma Saâda-Bouzid et al. · Annals of Oncology · 2020 · 73 citations

Medicine, Oncology, Pharmacology +17

Lenvatinib plus pembrolizumab for patients with previously treated biliary tract cancers in the multicohort phase II LEAP-005 study.

Luis J. Villanueva-Rivera, Zarnie Lwin, Hyun Cheol Chung et al. · Journal of Clinical Oncology · 2021 · 69 citations

Medicine, Oncology, Pharmacology +15